This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By: Pankey Gram The topic originally appeared on PankeyGram.org. Pankey gave up their permission to share with our igniteDDS readers. Treatment planning is a tricky and exhilarating stage in patient care, serving as the bridge between diagnosis and treatment. It’s where you outline the path to restoring your patient’s oral health and where patient trust is won or lost.
The United States Patent and Trademark Office recently issued patent 12,178,937 , entitled Compositions and Methods for Adhesion to Surfaces, which constitutes the 10th U.S. patent covering the TETRANITE bone adhesive technology. This patent expands the protected technology to include injectable mineral-organic structural bone adhesive compositions that comprise alpha-tricalcium phosphate.
Periapical lesions or radiolucencies around implants pose a unique challenge to the dental team. Retrograde peri-implantitis (RPI) is defined as a clinically symptomatic periapical lesion that develops after implant placement and maintains normal bone-to-implant contact at the coronal aspect. 1,2 The prevalence of RPI is generally very low. A retrospective study of 1,651 implants over 20 years noted a prevalence of RPI of 0.34%. 3 While there is no consensus about the etiology of RPI, several fa
What could the world’s most successful musician and the “Big Game” have to do with your dental practice? Turns out, a lot! If you want to provide an amazing patient experience and overcome your barriers to practice growth, don’t miss this episode of The Dental Practice Fixers podcast. Key Takeaways Embrace the power of experiences and adaptability to create a thriving dental practice.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 13,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content